PAR-22-031 - Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): AI/ML in Pre-Clinical Drug Development for Psychiatric Disorders | NOT-MH-25-050 | NIMH | Dec 20, 2024 | Jan 8, 2029 | R21, R01 |
Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs) | NOT-DA-25-032 | NIDA , NCCIH | Nov 25, 2024 | Jan 8, 2029 | R01, UG3/UH3, U01, R21 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|